Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
0.68
-0.01 (-1.45%)
At close: May 14, 2025, 3:59 PM
0.68
-0.03%
After-hours: May 14, 2025, 05:09 PM EDT
Spero Therapeutics Revenue
Spero Therapeutics reported an annual revenue of $27.4M, reflecting a -71.68% growth. For the quarter ending December 31, 2024, Spero Therapeutics generated $9.36M in revenue.
Revenue (ttm)
$27.4M
Revenue Growth
-71.68%
Price / Sales Ratio
2.03
Revenue / Employee
$856.13K
Employees
32
Market Cap
38.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|